NCT07798934

Brief Summary

This randomized controlled trial aims to determine whether white noise affects salivary cortisol levels and vital signs in adult patients undergoing gastroscopy. Participants will be randomly assigned to either a white noise group or a control group receiving routine care. Patients in the intervention group will listen to white noise in accordance with the study protocol. Saliva samples will be collected to assess cortisol levels, and vital signs will be measured at predetermined time points. The results of the two groups will be compared to evaluate whether white noise helps reduce the physiological stress response associated with gastroscopy.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Sep 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Sep 2026Feb 2027

First Submitted

Initial submission to the registry

August 27, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 2, 2026

Completed
25 days until next milestone

Study Start

First participant enrolled

September 27, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2027

Last Updated

September 2, 2026

Status Verified

September 1, 2026

Enrollment Period

5 months

First QC Date

August 27, 2026

Last Update Submit

September 1, 2026

Conditions

Keywords

White NoiseGastroscopySalivary CortisolVital SignsProcedural AnxietyPhysiological StressNursing InterventionRandomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Change in Salivary Cortisol Level

    Salivary cortisol concentration will be measured using an enzyme-linked immunosorbent assay (ELISA). The change from baseline will be calculated by subtracting the pre-procedure cortisol concentration from the post-procedure concentration and compared between the white noise and routine care groups. Higher cortisol concentrations indicate a greater physiological stress response.

    Perioperative and Periprocedural

Secondary Outcomes (7)

  • Change in Systolic Blood Pressure

    Perioperative and Periprocedural

  • Change in Diastolic Blood Pressure

    Perioperative and Periprocedural

  • Change in Heart Rate

    Perioperative and Periprocedural

  • Change in Respiratory Rate

    Perioperative and Periprocedural

  • Change in Peripheral Oxygen Saturation

    Perioperative and Periprocedural

  • +2 more secondary outcomes

Study Arms (2)

White Noise Intervention Group

EXPERIMENTAL

Participants will receive routine care and listen to white noise through headphones beginning immediately before entering the endoscopy room. White noise will continue uninterrupted during sedation induction and throughout the gastroscopy procedure and will be discontinued when the procedure is completed.

Behavioral: White Noise

Routine Care Control Group

NO INTERVENTION

Participants will receive routine care provided by the endoscopy unit without any auditory intervention during the gastroscopy procedure.

Interventions

White NoiseBEHAVIORAL

White noise will be delivered through headphones with disposable protective covers, beginning immediately before the participant enters the endoscopy room and continuing uninterrupted during sedation induction and throughout the gastroscopy procedure.

White Noise Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older
  • Scheduled for elective diagnostic gastroscopy under sedation
  • Able to communicate in Turkish
  • Able to hear the white noise intervention and without hearing loss that would prevent its use
  • Willing to participate voluntarily and able to provide written informed consent

You may not qualify if:

  • Undergoing emergency gastroscopy
  • Diagnosed psychiatric disorder or current use of psychotropic medication that may affect anxiety
  • Hearing impairment that would prevent effective delivery of the white noise intervention
  • Use of systemic, topical, or inhaled glucocorticoids within the previous month
  • Diagnosed adrenal or pituitary gland disorder
  • Pregnant or breastfeeding
  • Active oral lesions, gingival bleeding, or severe periodontitis that may compromise saliva sample quality
  • Smoking or consumption of caffeinated beverages within two hours before the procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Sogabe M, Okahisa T, Fukuya A, Kagemoto K, Okada Y, Adachi Y, Kurihara T, Nii T, Teramae S, Tanaka H, Tomonari T, Okamoto K, Miyamoto H, Nakasono M, Takayama T. Effects of audio and visual distraction on patients' vital signs and tolerance during esophagogastroduodenoscopy: a randomized controlled trial. BMC Gastroenterol. 2020 Apr 21;20(1):122. doi: 10.1186/s12876-020-01274-3.

  • Demirci S, Sezer S. Effect of Binaural Beats on Anxiety and Tolerance in Patients Undergoing Upper Gastrointestinal Endoscopy Without Sedation: A Randomized Controlled Trial. J Integr Complement Med. 2024 Dec;30(12):1209-1216. doi: 10.1089/jicm.2023.0804. Epub 2024 Aug 1.

  • Genc H, Tanriverdi S. The Effects of a Portative Glass Waterfall and a White Noise App On Pain, Anxiety, and Physiological Parameters During Gastroscopy. Pain Manag Nurs. 2026 Feb;27(1):e103-e111. doi: 10.1016/j.pmn.2025.10.001. Epub 2025 Oct 22.

Central Study Contacts

Zeynep GÜRKAN, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Saliva samples will be labeled with unique participant codes that do not reveal group assignment. Laboratory personnel performing the salivary cortisol analyses will remain blinded to the participants' allocation until the analyses are completed.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1 ratio to either the white noise intervention group or the routine care control group. Each participant will remain in the assigned group throughout the study, with no crossover between groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant, PhD

Study Record Dates

First Submitted

August 27, 2026

First Posted

September 2, 2026

Study Start

September 27, 2026

Primary Completion (Estimated)

February 15, 2027

Study Completion (Estimated)

February 15, 2027

Last Updated

September 2, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share